Whole exome sequence analysis reveals a homozygous mutation in PNPLA2 as the cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cardiology

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2016.02.082PMID 26922712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Whole‐exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory

  2015cited by this paper
• A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.

  2014cited by this paper
• PNPLA2 mutation: a paediatric case with early onset but indolent course.

  2013cited by this paper
• Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.

  2013cited by this paper
• Symptomatic lipid storage in carriers for the PNPLA2 gene

  2012cited by this paper
• Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.

  2012cited by this paper
• The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene

  2011cited by this paper
• Investigation and Functional Characterization of Rare Genetic Variants in the Adipose Triglyceride Lipase in a Large Healthy Working Population

  2010cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• BIOINFORMATICS APPLICATIONS NOTE

  2001cited by this paper

• Dilated cardiomyopathy caused by mutation of the PNPLA2 gene: a case report and literature review

  2024cites this paper
• HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy.

  2023cites this paper
• Identification of Differential Expression Genes between Volume and Pressure Overloaded Hearts Based on Bioinformatics Analysis

  2022cites this paper
• Early onset neutral lipid storage disease with myopathy presenting as congenital hypotonia and hepatomegaly.

  2020cites this paper
• Metabolic Myopathies II

  2020cites this paper
• Triglyceride Deposit Cardiomyovasculopathy

  2019cites this paper
• Myocardial Adipose Triglyceride Lipase Overexpression Protects against Burn-Induced Cardiac Lipid Accumulation and Injury

  2019cites this paper
• The homozygous variant c.245G > A/p.G82D in PNPLA2 is associated with arrhythmogenic cardiomyopathy phenotypic manifestations

  2019cites this paper
• Lipid storage myopathies: Current treatments and future directions.

  2018cites this paper